Clinical trial
An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to…
NCT00240838 · Johnson & Johnson Consumer and Personal Products Worldwide, Industry · Completed
Key facts
| NCT number | NCT00240838 |
|---|---|
| Title | An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness. |
| Official title | A Randomized, Double-Blind Study Evaluating Acetaminophen Extended Release Caplets (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness. |
| Lead sponsor | Johnson & Johnson Consumer and Personal Products Worldwide, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | acetaminophen extended release caplets |
| Enrollment | 483 |
| Start date | May 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Oct 18, 2005 |
| Last update posted | Jun 29, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: